NCBiotech News

Four lucky Durham Technical Community College students will soon pioneer a bold new apprenticeship program with Durham-based KBI Biopharma designed to groom more workers for pharmaceutical manufacturing.

On Friday, May 7, 2021, Alamance Community College will observe the groundbreaking of its groundbreaking $17.6 million Biotechnology Center of Excellence.

Abzena, a global British contract development and manufacturing organization (CDMO), has announced a $213 million plan to build a new factory in the Lee County city of Sanford, ultimately adding 325 employees by the end of 2025 to the fast-growing North Carolina biomanufacturing ecosystem.

bluebird bio has hit a major milestone, garnering U.S. Food and Drug Administration approval to market its first product in the U.S., which is also its first cell therapy designed to treat cancer. It's partnered with Bristol Myers on the product launch.

Raybow USA, a custom chemical research and development company in the western North Carolina city of Brevard, has announced plans to invest $15.8 million over the next five years in an expansion that will add 74 employees to its current workforce of 26.

FUJIFILM Corporation today ended a high-stakes economic development drama by announcing that Holly Springs, N.C., is officially its choice for siting a $2 billion biomanufacturing site that will employ 725 over five years.

NC State University and Novozymes have been combining forces to produce more than 2,400 gallons of hand sanitizer to help keep NC State students, faculty and staff safer, as well as people at the NC Museum of Natural Sciences in Raleigh.

Global pharmaceutical giant Merck has confirmed that its flagship Durham vaccine manufacturing facility is gearing up to help competitor Johnson & Johnson produce COVID-19 vaccine.

Biogen has announced a $200 million investment to support clinical production for its gene therapy pipeline. The company plans to add 90 more workers to its workforce of 1,900 people at its two facilities in the Research Triangle Park.

Expansions announced in 2020 will bring more than $2.3 billion in investment and 2,800 new jobs in biopharma manufacturing to North Carolina in coming months and years.

Life sciences manufacturing companies in North Carolina expanded their collective workforce by more than 11%.in 2020, in sharp contrast to the global economic downturn wrought by the COVID-19 pandemic.

The Golden LEAF Foundation has awarded nearly $1.9 million to help East Carolina University expand its burgeoning pharmaceutical manufacturing workforce training program.

A year-old RTP nonprofit, Med Aditus International, founded by retired UNC pharmacy prof Dhiren R. Thakker, Ph.D., is about to launch a game-changing pharmaceutical manufacturing and training initiative to provide affordable, high-quality medicines in sub-Saharan Africa.

Global biotherapeutics giant Grifols will soon start a clinical trial for what could become the second approved treatment for COVID-19.

A Jan. 28 virtual symposium, “BioGrow: Training and Education Across North Carolina,” is planned to get the word out to anyone interested in a career in biopharmaceuticals.